These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36442480)

  • 1. Efficacy of frankincense-based herbal product in urinary incontinence: A randomized, double-blind, placebo- and active-controlled clinical trial.
    Karbalaiee M; Daneshpajooh A; Khanjani N; Sohbati S; Mehrabani M; Mehrbani M; Mehrabani M
    Phytother Res; 2023 May; 37(5):1754-1770. PubMed ID: 36442480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's disease.
    Zesiewicz TA; Evatt M; Vaughan CP; Jahan I; Singer C; Ordorica R; Salemi JL; Shaw JD; Sullivan KL;
    Parkinsonism Relat Disord; 2015 May; 21(5):514-20. PubMed ID: 25814050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Efficacy and Safety of OnabotulinumtoxinA or Solifenacin Compared with Placebo in Solifenacin Naïve Patients with Refractory Overactive Bladder: Results from a Multicenter, Randomized, Double-Blind Phase 3b Trial.
    Herschorn S; Kohan A; Aliotta P; McCammon K; Sriram R; Abrams S; Lam W; Everaert K
    J Urol; 2017 Jul; 198(1):167-175. PubMed ID: 28161352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroacupuncture versus solifenacin for women with urgency-predominant mixed urinary incontinence: a protocol for a three-armed non-inferiority randomized controlled trial.
    Sun Y; Liu Y; Su T; Sun J; Wu Y; Liu Z
    BMC Complement Med Ther; 2020 Jan; 20(1):18. PubMed ID: 32020889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study).
    Herschorn S; Chapple CR; Abrams P; Arlandis S; Mitcheson D; Lee KS; Ridder A; Stoelzel M; Paireddy A; van Maanen R; Robinson D
    BJU Int; 2017 Oct; 120(4):562-575. PubMed ID: 28418102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE).
    Drake MJ; Chapple C; Esen AA; Athanasiou S; Cambronero J; Mitcheson D; Herschorn S; Saleem T; Huang M; Siddiqui E; Stölzel M; Herholdt C; MacDiarmid S;
    Eur Urol; 2016 Jul; 70(1):136-145. PubMed ID: 26965560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of frankincense (Boswellia serrata, oleoresin) and ginger (Zingiber officinale, rhizoma) on heavy menstrual bleeding: A randomized, placebo-controlled, clinical trial.
    Eshaghian R; Mazaheri M; Ghanadian M; Rouholamin S; Feizi A; Babaeian M
    Complement Ther Med; 2019 Feb; 42():42-47. PubMed ID: 30670277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: Results from the double-blind, randomized, active- and placebo-controlled SONIC urodynamic study.
    Amarenco G; Sutory M; Zachoval R; Agarwal M; Del Popolo G; Tretter R; Compion G; De Ridder D
    Neurourol Urodyn; 2017 Feb; 36(2):414-421. PubMed ID: 26714009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solifenacin in Children and Adolescents with Overactive Bladder: Results of a Phase 3 Randomised Clinical Trial.
    Newgreen D; Bosman B; Hollestein-Havelaar A; Dahler E; Besuyen R; Sawyer W; Bolduc S; Rittig S
    Eur Urol; 2017 Mar; 71(3):483-490. PubMed ID: 27687820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved quality of life in patients with overactive bladder symptoms treated with solifenacin.
    Kelleher CJ; Cardozo L; Chapple CR; Haab F; Ridder AM
    BJU Int; 2005 Jan; 95(1):81-5. PubMed ID: 15638900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder.
    Cardozo L; Lisec M; Millard R; van Vierssen Trip O; Kuzmin I; Drogendijk TE; Huang M; Ridder AM
    J Urol; 2004 Nov; 172(5 Pt 1):1919-24. PubMed ID: 15540755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A; Wyndaele JJ; Sieber P
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Femaxeen® for control of urinary incontinence in women: A randomized, double-blind, placebo-controlled study.
    Palacios S; Ramirez M; Lilue M; Vega B
    Maturitas; 2020 Mar; 133():1-6. PubMed ID: 32005419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy: Responder Analyses and Patient-Reported Outcomes from the BESIDE Study [corrected].
    MacDiarmid S; Al-Shukri S; Barkin J; Fianu-Jonasson A; Grise P; Herschorn S; Saleem T; Huang M; Siddiqui E; Stölzel M; Hemsted C; Nazir J; Hakimi Z; Drake MJ;
    J Urol; 2016 Sep; 196(3):809-18. PubMed ID: 27063854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
    Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
    Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of solifenacin on postvoid dribbling in women: results of a randomized, double-blind placebo-controlled trial.
    Ablove T; Bell LN; Liang H; Chappell RJ; Toklu HZ; Yale SH
    Int Urogynecol J; 2018 Jul; 29(7):1051-1060. PubMed ID: 29574484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, placebo-controlled trial to compare solifenacin versus trospium chloride in the relief of double-J stent-related symptoms.
    Abdelhamid MH; Zayed AS; Ghoneima WE; Elmarakbi AA; El Sheemy MS; Aref A; Abdelbary A; Nour HH
    World J Urol; 2017 Aug; 35(8):1261-1268. PubMed ID: 28050642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of solifenacin succinate tablets versus solifenacin succinate tablets with local estrogen for the treatment of overactive bladder in postmenopausal women--a multicenter, randomized, open-label, controlled comparison study.
    Jiang F; Zhu L; Xu T; Gong MY; Huang YL; Li HF; Wang JJ; Tong XW; Cheng XX; Bai WP; Li X; Xu XX; Xu HC
    Menopause; 2016 Apr; 23(4):451-7. PubMed ID: 26757270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence.
    Staskin DR; Te AE
    BJU Int; 2006 Jun; 97(6):1256-61. PubMed ID: 16686722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in women with urinary incontinence seeking care using e-health.
    Åström Y; Asklund I; Lindam A; Sjöström M
    BMC Womens Health; 2021 Sep; 21(1):337. PubMed ID: 34544393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.